FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362673626> ?p ?o ?g. }

• W4362673626 endingPage "e002923" @default.
• W4362673626 startingPage "e002923" @default.
• W4362673626 abstract "To assess outcomes in giant cell arteritis (GCA) patients during and after long-term tocilizumab (TCZ) treatment.Retrospective analysis of GCA patients treated with TCZ at a single centre (2010-2022). Time to relapse and annualised relapse rate during and after TCZ treatment, prednisone use, and safety were assessed. Relapse was defined as reappearance of any GCA clinical manifestation that required treatment intensification, regardless of C reactive protein levels and erythrocyte sedimentation rate.Sixty-five GCA patients were followed for a mean (SD) of 3.1 (1.6) years. The mean duration of the initial TCZ course was 1.9 (1.1) years. The Kaplan-Meier (KM)-estimated relapse rate at 18 months on TCZ was 15.5%. The first TCZ course was discontinued due to satisfactory remission achievement in 45 (69.2%) patients and adverse events in 6 (9.2%) patients. KM-estimated relapse rate at 18 months after TCZ discontinuation was 47.3%. Compared with patients stopping TCZ at or before 12 months of treatment, the multivariable adjusted HR (95% CI) for relapse in patients on TCZ beyond 12 months was 0.01 (0.00 to 0.28; p=0.005). Thirteen patients received >1 TCZ course. Multivariable adjusted annualised relapse rates (95% CI) in all periods on and off TCZ aggregated were 0.1 (0.1 to 0.2) and 0.4 (0.3 to 0.7), respectively (p=0.0004). Prednisone was discontinued in 76.9% of patients. During the study, 13 serious adverse events occurred in 11 (16.9%) patients.Long-term TCZ treatment was associated with remission maintenance in most patients with GCA. The estimated relapse rate by 18 months after TCZ discontinuation was 47.3%." @default.
• W4362673626 created "2023-04-07" @default.
• W4362673626 creator A5005075651 @default.
• W4362673626 creator A5013798522 @default.
• W4362673626 creator A5028698578 @default.
• W4362673626 creator A5040865719 @default.
• W4362673626 creator A5041210662 @default.
• W4362673626 creator A5042482253 @default.
• W4362673626 creator A5054201991 @default.
• W4362673626 date "2023-04-01" @default.
• W4362673626 modified "2023-09-26" @default.
• W4362673626 title "Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis" @default.
• W4362673626 cites W1995278898 @default.
• W4362673626 cites W1997568521 @default.
• W4362673626 cites W2004589503 @default.
• W4362673626 cites W2012858896 @default.
• W4362673626 cites W2053328369 @default.
• W4362673626 cites W2056768892 @default.
• W4362673626 cites W2060549798 @default.
• W4362673626 cites W2062077446 @default.
• W4362673626 cites W2292169217 @default.
• W4362673626 cites W2362038500 @default.
• W4362673626 cites W2558363236 @default.
• W4362673626 cites W2581891606 @default.
• W4362673626 cites W2737436316 @default.
• W4362673626 cites W2785039038 @default.
• W4362673626 cites W2961711096 @default.
• W4362673626 cites W3120992738 @default.
• W4362673626 cites W3135997688 @default.
• W4362673626 cites W3165270842 @default.
• W4362673626 cites W3165282142 @default.
• W4362673626 cites W3165521566 @default.
• W4362673626 cites W3177888126 @default.
• W4362673626 cites W3194332798 @default.
• W4362673626 cites W4221065818 @default.
• W4362673626 cites W4247851911 @default.
• W4362673626 cites W4297004032 @default.
• W4362673626 cites W4307155224 @default.
• W4362673626 cites W4309097107 @default.
• W4362673626 doi "https://doi.org/10.1136/rmdopen-2022-002923" @default.
• W4362673626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37024237" @default.
• W4362673626 hasPublicationYear "2023" @default.
• W4362673626 type Work @default.
• W4362673626 citedByCount "0" @default.
• W4362673626 crossrefType "journal-article" @default.
• W4362673626 hasAuthorship W4362673626A5005075651 @default.
• W4362673626 hasAuthorship W4362673626A5013798522 @default.
• W4362673626 hasAuthorship W4362673626A5028698578 @default.
• W4362673626 hasAuthorship W4362673626A5040865719 @default.
• W4362673626 hasAuthorship W4362673626A5041210662 @default.
• W4362673626 hasAuthorship W4362673626A5042482253 @default.
• W4362673626 hasAuthorship W4362673626A5054201991 @default.
• W4362673626 hasBestOaLocation W43626736261 @default.
• W4362673626 hasConcept C126322002 @default.
• W4362673626 hasConcept C141071460 @default.
• W4362673626 hasConcept C197934379 @default.
• W4362673626 hasConcept C2776015282 @default.
• W4362673626 hasConcept C2776712624 @default.
• W4362673626 hasConcept C2777178219 @default.
• W4362673626 hasConcept C2777575956 @default.
• W4362673626 hasConcept C2778143017 @default.
• W4362673626 hasConcept C2778715236 @default.
• W4362673626 hasConcept C2778720950 @default.
• W4362673626 hasConcept C2779134260 @default.
• W4362673626 hasConcept C71924100 @default.
• W4362673626 hasConcept C90924648 @default.
• W4362673626 hasConceptScore W4362673626C126322002 @default.
• W4362673626 hasConceptScore W4362673626C141071460 @default.
• W4362673626 hasConceptScore W4362673626C197934379 @default.
• W4362673626 hasConceptScore W4362673626C2776015282 @default.
• W4362673626 hasConceptScore W4362673626C2776712624 @default.
• W4362673626 hasConceptScore W4362673626C2777178219 @default.
• W4362673626 hasConceptScore W4362673626C2777575956 @default.
• W4362673626 hasConceptScore W4362673626C2778143017 @default.
• W4362673626 hasConceptScore W4362673626C2778715236 @default.
• W4362673626 hasConceptScore W4362673626C2778720950 @default.
• W4362673626 hasConceptScore W4362673626C2779134260 @default.
• W4362673626 hasConceptScore W4362673626C71924100 @default.
• W4362673626 hasConceptScore W4362673626C90924648 @default.
• W4362673626 hasFunder F4320332193 @default.
• W4362673626 hasIssue "2" @default.
• W4362673626 hasLocation W43626736261 @default.
• W4362673626 hasLocation W43626736262 @default.
• W4362673626 hasLocation W43626736263 @default.
• W4362673626 hasOpenAccess W4362673626 @default.
• W4362673626 hasPrimaryLocation W43626736261 @default.
• W4362673626 hasRelatedWork W1995278898 @default.
• W4362673626 hasRelatedWork W2792261031 @default.
• W4362673626 hasRelatedWork W2808446992 @default.
• W4362673626 hasRelatedWork W2906121354 @default.
• W4362673626 hasRelatedWork W2910835074 @default.
• W4362673626 hasRelatedWork W2933866602 @default.
• W4362673626 hasRelatedWork W2952904541 @default.
• W4362673626 hasRelatedWork W3165270842 @default.
• W4362673626 hasRelatedWork W3196284155 @default.
• W4362673626 hasRelatedWork W4291186675 @default.
• W4362673626 hasVolume "9" @default.
• W4362673626 isParatext "false" @default.

• next